Q/C Technologies Inc QCLS

$0.45 -0.02 (-4.93%)

Valuation

Market cap
3,874,000
Revenue TTM
$0
Net income TTM
$-11,630,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
213,800
Avg volume
6,325,910
Day's range
$0.42 – $0.51
Shares out
8,190,000
Stochastic %K
15%
Beta
2.32
Analysts
Strong Buy
Price target
—

Price

Company profile

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowe...

Show more

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company. It operates through Pharmaceuticals and Computing Technology segments. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. In addition, it is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications;. The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.

Industry
Computer Hardware
Sector
Technology
Phone
856 848 8698
Website
https://www.qctechnologies.com
Address
1185 Avenue of the Americas, Suite 249, New York, United States

Latest news

Stocktwits

Iiontamer Oct 26, 8:39 PM
$QCLS remember this is a top Martin Shrekli pick. He said this is the future 
0 replies
Jojorida Oct 26, 8:29 PM
$QCLS
0 replies
Fergcheesy Oct 23, 8:46 PM
$QCLS
0 replies
Jojorida Oct 23, 7:50 PM
$QCLS
0 replies
NoNameMeme Oct 22, 5:09 AM
$QCLS Looking for a 1-for-30 (0.0333333:1) R/S again 😆 This company needs to be OTC'd ASAP they have been duping people for way too long already.
0 replies
bninawhile Oct 21, 12:18 PM
$QCLS risk remains the company not a reverse split or delisting they have another many days before getting a notice for under a buck then 180 days and likely another 180 after that from what I can tell Making a company if their risk and not sure what they are going to manage
0 replies
Jojorida Oct 20, 11:46 AM
$QCLS here comes 0.4 then 0.3 , mark my words
0 replies
Jojorida Oct 19, 8:04 PM
$QCLS has not managed to present anything concrete for many many years. Will it end here, Cause the RS is not allowed right?
0 replies